Nasdaq Stockholm

Prostatype Genomics AB

ISIN SE0014684569Filings at the FI

At a glance

Most recent filing on September 1, 2026 — an option exercise by Michael Häggman on Sep 1, 2026.

We hold 22 visible filings, going back to November 3, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 22 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 22. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Michael Häggman Board member
71,500 SEKOption exercise
TradedSep 1, 2026FiledSep 1, 2026
Michael Häggman Board member
1,697 SEKOpen-market sale
TradedAug 31, 2026FiledSep 1, 2026
Michael Häggman Board member
325,000 SEKOpen-market buy
TradedSep 23, 2024FiledSep 30, 2024
Anders Lundberg Chair of the board
11,152 SEKOpen-market sale
TradedSep 5, 2024FiledSep 9, 2024
Anders Lundberg Chair of the board
27,916 SEKOpen-market sale
TradedSep 6, 2024FiledSep 9, 2024